Shibu Thomas
Senior Scientific Director, Biomarkers Johnson & Johnson
Shibu Thomas, PhD, is Senior Scientific Director, Oncology Translational Research at Johnson & Johnson (Janssen), a role held since April 2022. He has been at Janssen since 2012, progressing from Senior Scientist, Biomarker Lead. Previously, he held research roles at the University of Virginia and VCU Institute of Molecular Medicine.
Seminars
Friday 19th March 2027
Building a Multimodal Biomarker Profile: Combining Urine & Plasma ctDNA, RNA & Spatial Biology to Make Bladder-Preservation Decisions with Confidence
8:30 am
- Comparing personalized, fixed panel and methylation approaches head-to-head in the same patients to find the sensitivity needed for real clinical decisions
- Combining urine and plasma ctDNA with spatial and transcriptomic data to build a more complete patient profile
- Scaling deeper science into practical diagnostics, including where histopathology AI can reduce testing bottlenecks
Friday 19th March 2027
Panel Discussion: Harnessing Multimodal Technologies to Improve Patient Profiling for Increased Accuracy in Diagnostics
9:30 am
- Integrating protein, methylation and fragmentomic signal to resolve cases that genomic profiling alone leaves ambiguous
- Determining which analyte combinations improve accuracy enough to justify the added cost and complexity
- Embedding multi-omic workflows into patient selection and diagnostic paradigms
